Tag: Comirnaty
-
COVID Jab Gets Permanent Liability Protection as Predicted
by Dr. Joseph Mercola, ©2023 (Feb. 21, 2023) — Well, as predicted, the COVID shots have now received a permanent liability shield against injury and death. October 20, 2022, the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) unanimously (15-0) voted to add unlicensed COVID-19 shots to the U.S. childhood,…
-
Where is “Comirnaty?”
by Sharon Rondeau (Feb. 4, 2022) — On January 29, 2022, The Post & Email published a response received from a spokesman for the U.S. Food and Drug Administration (FDA) regarding the abrupt withdrawal of two monoclonal antibody products used to combat COVID-19 in higher-risk individuals as well as the safety and efficacy of the…
-
BMJ Demands Immediate Vaccine Data
by Dr. Joseph Mercola, public domain (Feb. 1, 2022) — While other Big Pharma manufacturers have developed and released a COVID-19 genetic therapy injection, only shots from Pfizer, Moderna and Johnson & Johnson have been approved in the U.S.1 The British Medical Journal (BMJ) editor Peter Doshi, an associate professor of pharmaceutical health services research…
-
FDA Responds to The Post & Email’s Questions on Withdrawn Treatments, Vaccine Safety
by Sharon Rondeau (Jan. 29, 2021) — On Monday the FDA announced it would “limit use” of two types of monoclonal antibodies to fight COVID-19, which some criticized as a decision made without any supporting “clinical data.” “As we have throughout the COVID-19 pandemic, the U.S. Food and Drug Administration has used the best available…
-
The Real Reason they Want to Give COVID Jabs to Kids
by Dr. Joseph Mercola, public domain (Dec. 27, 2021) — In this interview, Alix Mayer explains why our children are being so aggressively targeted for the COVID-19 injection even though they’re not at risk of serious SARS-CoV-2 infection, and clarifies the status of Comirnaty. Mayer, board president of Children’s Health Defense — California Chapter, is…
-
Why Can’t the FDA Answer These Simple Questions?
by Sharon Rondeau (Oct. 2, 2021) — Questions The Post & Email posed more than a week ago to the FDA regarding COVID-19 vaccines remain unanswered despite person-to-person contact between this writer and an FDA representative. On Wednesday, September 22, The Post & Email contacted the FDA’s Center for Biologics Evaluation and Research (CBER) by…